Interferon-β inhibits Th1 responses at the dendritic cell level: Relevance to multiple sclerosis

Acta Neurologica Belgica

Volumn 99, Issue 1, 1999, Pages 44-52

  Bartholome E J ^a   Willems, F ^a,b   Crusiaux, A ^a   Thielemans, K ^c   Schandene L ^a   Goldman, M ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

CD40; Dendritic cells; Human; Interferon ; Interleu; Kin 12; Multiple sclerosis; Th1 th2

Indexed keywords

BETA INTERFERON; CD40 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; HLA B7 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 12; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITE; DRUG MECHANISM; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOTHERAPY; MULTIPLE SCLEROSIS;

EID: 0032946720     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. ARNASON B. G. Interferon beta in multiple sclerosis. Clin. Immunol. Immunopathol., 1996, 81 : 1-11.
2. ARNASON B. G., REDER A. T. Interferons and Multiple Sclerosis. Clin. Neuropharmacol., 1994, 17 : 495-547.
3. BALASHOV K. E., SMITH D. R., KHOURY S. J., HAFLER D. A., WEINER H. L. Increased interleukin 12 production in progressive multiple sclerosis : induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U.S.A., 1997, 94 : 599-603.
4. BANCHEREAU J., STEINMAN R. M. Dendritic cells and the control of immunity. Nature, 1998, 392 : 245-252.
5. BONGIOANNI M. R., DURELLI L., FERRERO B., IMPERIALE D., OGGERO A. et al. Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis. J. Neurol. Sci., 1996, 143 : 91-99.
6. BROD S. A., MARSHALL G. D., Jr., HENNINGER E. M., SRIRAM S., KHAN M. et al. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology, 1996, 46 : 1633-1638.
7. BUELENS C., VERHASSELT V., DE GROOTE D., THIELEMANS K., GOLDMAN M. et al. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol., 1997a, 27 : 756-762.
8. BUELENS C., VERHASSELT V., DE GROOTE D., THIELEMANS K., GOLDMAN M. et al. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol., 1997b, 27 : 1848-1852.
9. BYSKOSH P., REDER A. T. Interferon-β-1b effects on Cytokine mRNA in Multiple Sclerosis. Ann. Neurol., 1995, 38 : 340(Abstract)
10. CALABRESI P. A., TRANQUILL L. R., STONE L. A., COWAN E. P., MCFARLAND H. F. Cytokine mRNA Expression Changes in CSF Cells From Multiple Sclerosis Patients Treated with Betaseron. Neurology, 1996, 46 : A165(Abstract)
11. CALABRESI P. A., TRANQUILL L. R., DAMBROSIA J. M., STONE L. A., MALONI H. et al. Increases in Soluble VCAM-1 Correlate with a Decrease in MRI Lesions in Multiple Sclerosis Treated with Interferon b-1b. Ann. Neurol., 1997, 41 : 669-674.
12. CELLA M., SCHEIDEGGER D., PALMER-LEHMANN K., LANE P., LANZAVECCHIA A. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity : T-T help via APC activation. J. Exp. Med., 1996, 184 : 747-752.
13. COOK S. D., DOWLING P. C. Multiple sclerosis and viruses : An overview. Neurology, 1980, 30 : 80-91.
14. COUSENS L. P., ORANGE J. S., SU H. C., BIRON C. A. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. U.S.A., 1997, 94 : 634-639.
15. CROFT M., DUNCAN D. D., SWAIN S. L. Response of naive antigen-specific CD4+ T cells in vitro : characteristics and antigen-presenting cell requirements. J. Exp. Med., 1992, 176 : 1431-1437.
16. CRUCIAN B., DUNNE P., FRIEDMAN H., RAGSDALE R., PROSS S. et al. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin. Diagn. Lab. Immunol., 1996, 3 : 411-416.
17. DAYAL A. S., JENSEN M. A., LLEDO A., ARNASON B. G. Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology, 1995, 45 : 2173-2177.
18. DEMEURE C. E., WU C. Y., SHU U., SCHNEIDER P. V., HEUSSER C. et al. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol., 1994, 152 : 4775-4782.
19. FAGNONI F. F., TAKAMIZAWA M., GODFREY W. R., RIVAS A., AZUMA M. et al. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. Immunology, 1995, 85 : 467-474.
20. GENC K., DONA D. L., REDER A. T. Increased CD80+ B Cells in Active Multiple Sclerosis and Reversal by Interferon b-1b Therapy. J. Clin. Invest., 1997, 99 : 2664-2671.
21. GERRITSE K., LAMAN J. D., NOELLE R.J., ARUFFO A., LEDBETTER J. A. et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A., 1996, 93 : 2499-2504.
22. GRAF D., KORTHAUER U., MAGES H. W., SENGER G., KROCZEK R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol., 1992, 22 : 3191-3194.
23. GUERY J. C., ADORINI L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol., 1995, 154 : 536-544.
24. HAAHR S., MOLLER-LARSEN A., JUSTESEN J., PEDERSEN E. Interferon induction, 2′-5′ oligo A synthetase and lymphocyte subpopulations in outpatients with multiple sclerosis in a longitudinal study. Acta. Neurol. Scand., 1986, 73 : 345-351.
25. HERMANN P., RUBIO M., NAKAJIMA T., DELESPESSE G., SARFATI M. IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. J. Immunol., 1998, 161 : 2011-2018.
26. HEUFLER C., KOCH F., STANZL U., TOPAR G., WYSOCKA M. et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol., 1996, 26 : 659-668.
27. HIRSCH R. L., JOHNSON K. P. The effects of long-term administration of recombinant alpha-2 interferon on lymphocytes subsets, proliferation, and suppressor cell function in multiple sclerosis. J. Interferon. Res., 1986, 6 : 171-177.
28. ISSAZADEH S., LJUNGDAHL A., HOJEBERG B., MUSTAFA M., OLSSON T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis : dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J. Neuroimmunol., 1995, 61 : 205-212.
29. JACOBS L. D., COOKFAIR D. L., RUDICK R. A., HERNDON R. M., RICHERT J. R. et al. Intramuscular interferon beta-1 a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann. Neurol., 1996, 39 : 285-294.
30. KOCH F., STANZL U., JENNEWEIN P., JANKE K., HEUFLER C. et al. High level IL-12 production by murine dendritic cells : upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med., 1996, 184 : 741-746.
31. LEONARD J. P., WALDBURGER K. E., GOLDMAN S. J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 1995, 181 : 381-386.
32. LEPPERT D., WAUBANT E., BURK M. R., OKSENBERG J. R., HAUSER S. L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells : a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol., 1996, 40 : 846-852.
33. LUFT T., PANG K. C., THOMAS E., HERTZOG P., HART D. N. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol., 1998, 161 : 1947-1953.
34. MACATONIA S. E., HOSKEN N. A., LITTON M., VIEIRA P., HSIEH C. S. et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol., 1995, 154 : 5071-5079.
35. MANETTI R., ANNUNZIATO F., TOMASEVIC L., GIANNO V., PARRONCHI P. et al. Polyinosinic acid : polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur. J. Immunol., 1995, 25 : 2656-2660.
36. MCRAE B. L., SEMNANI R. T., HAYES M. P., VAN SEVENTER G. A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol., 1998, 160 : 4298-4304.
37. MILO R., PANITCH H. Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein. J. Neuroimmunol., 1995, 61 : 185-193.
38. NEIGHBOUR P. A. Studies of Interferon Production and Natural Killing by Lymphocytes from Multiple Sclerosis Patients. Ann. N. Y. Acad. Sci., 1984, 436 : 181-191.
39. NEIGHBOUR P. A., BLOOM B. R. Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc. Natl. Acad. Sci. USA, 1979, 76 : 476-480.
40. NORONHA A., TOSCAS A., JENSEN M. A. Interferon Beta Augments Suppressor Cell Function in Multiple Sclerosis. Ann. Neurol., 1990, 27 : 207-210.
41. NORONHA A., TOSCAS A., JENSEN M. A. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis. Ann. Neurol., 1992, 31 : 103-106.
42. NORONHA A., JENSEN M. A., TOSCAS A. TGF-β activity in MS : effect of IFN-β. Neurology, 1993a, 43 : 355(Abstract)
43. NORONHA A., TOSCAS A., JENSEN M. A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol., 1993b, 46 : 145-153.
44. NORONHA A., TOSCAS A., ARNASON B. G., JENSEN M. A. IFN-beta augments in vivo suppressor function in MS. Neurology, 1994, 44 : A212 (Abstract).
45. O'GORMAN M. R. G., OGER J., KASTRUKOFF L. F. Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients. Clin. Exp. Immunol., 1987, 67 : 66-75.
46. OLIVE D., RAYMOND J., DUBREUIL P., CHARMOT D., JACQUES Y. et al. Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth. Eur. J. Immunol., 1986, 16 : 611-616.
47. PANITCH H. S., FOLUS J. S., JOHNSON K. P. Recombinant Beta Interferon Inhibits Gamma Interferon Production in Multiple Sclerosis. Ann. Neurol., 1987, 22 : 139 (Abstract).
48. PANITCH H. S., FOLUS J. S., JOHNSON K. P. Beta Interferon Prevents HLA Class II Antigen Induction by Gamma Interferon in MS. Neurology, 1989, 39 : 171.
49. PANITCH H. S. Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol., 1994, 36 Suppl. : S25-8.
50. PARRONCHI P., DE CARLI M., MANETTI R., SIMONELLI C., SAMPOGNARO S. et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol., 1992, 149 : 2977-2983.
51. PARRONCHI P., MOHAPATRA S., SAMPOGNARO S., GIANNARINI L., WAHN U. et al. Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur. J. Immunol., 1996, 26 : 697-703.
52. PORRINI A. M., GAMBI D., REDER A. T. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J. Neuroimmunol., 1995, 61 : 27-34.
53. RANSOHOFF R. M., DEVAJYOTHI C., ESTES M. L., BABCOCK G., RUDICK R. A. et al. Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol., 1991, 33 : 103-112.
54. ROMANI N., GRUNER S., BRANG D., KAMPGEN E., LENZ A. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 1994, 180 : 83-93.
55. RUDICK R. A., RANSOHOFF R. M., PEPPLER R., VANDERBRUG MEDENDORP S., LEHMANN P. et al. Interferon beta induces interleukin-10 expression : relevance to multiple sclerosis. Ann. Neurol., 1996, 40 : 618-627.
56. SALONEN R., ILONEN J., REUNANEN M., SALMI A. Defective production of interferon-α associated with HLA-Dw2 antigen in stable multiple sclerosis. J. Neurol. Sci., 1982, 55 : 197-206.
57. SANTOLI D., HALL W., KASTRUKOFF L. F., LISAK R. P., PERUSSIA B. et al. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J. Immunol., 1981, 126 : 1274-1278.
58. SCHANDENE L., DEL PRETE G. F., COGAN E., STORDEUR P., CRUSIAUX A. et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J. Clin. Invest., 1996, 97 : 309-315.
59. SIBLEY W.A., BAMFORD C.R., SUZUKI N. Clinical viral infections and multiple sclerosis. Lancet, 1985, 1 : 1313-1315.
60. SPEAR G. T., PAULNOCK D. M., JORDAN R. L., MELTZER D. M., MERRITT J. A. et al. Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon. Clin. Exp. Immunol., 1987, 69 : -115.
61. STUVE O., DOOLEY N. P., UHM J. H., ANTEL J. P., FRANCIS G. S. et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro : effects on matrix metalloproteinase-9. Ann. Neurol., 1996, 40 : 853-863.
62. SZTEIN M. B., STEEG P. S., JOHNSON H. M., OPPENHEIM J. J. Regulation of human Peripheral Blood Monocyte DR Antigen Expression In Vitro by Lymphokines and Recombinant Interferons. J. Clin. Invest., 1984, 73 : 556-565.
63. THE IFNB MULTIPLE SCLEROSIS STUDY GROUP Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-ßlind, placebo-controlled trial. Neurology, 1993, 43 : 655-661.
64. THE IFNB MULTIPLE SCLEROSIS STUDY GROUP, THE UNIVERSITY OF BRITISH COLUMBIA MS/MRI ANALYSIS GROUP Interferon beta-1b in the treatment of multiple sclerosis : final outcome of the randomized controlled trial. Neurology, 1995, 45 : 1277-1285.
65. THOMAS R., DAVIS L. S., LIPSKY P. E. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J. Immunol., 1993, 151 : 6840-6852.
66. TOVELL D. R., MCROBBIE I. A., WARREN K. G., TYRRELL D. L. J. Interferon production by lymphocytes from multiple sclerosis and non-MS patients. Neurology, 1983, 33 : 640-643.
67. VERHASSELT V., BUELENS C., WILLEMS F., DE GROOTE D., HAEFFNER-CAVAILLON N. et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol., 1997, 158 : 2919-2925.
68. VERVLIET G., CARTON H., MEULEPAS E., BILLIAU A. Interferon production by cultured peripheral leucocytes of MS patients. Clin. Exp. Immunol., 1984, 58 : 116-126.
69. VERVLIET G., CARTON H., BILLIAU A. Interferon-gamma production by peripheral blood leukocytes from patients with multiple sclerosis and other neurological diseases. Clin. Exp. Immunol., 1985, 59 : 391-397.
70. WEINSTOCK GUTTMAN B., RANSOHOFF R. M., KINKEL R. P., RUDICK R. A. The Interferons : Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis. Ann. Neurol., 1995, 37 : 7-15.
71. WENNER C. A., GULER M. L., MACATONIA S. E., O'GARRA A., MURPHY K. M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol., 1996, 156 : 1442-1447.
72. WINDHAGEN A., NEWCOMBE J., DANGOND F., STRAND C., WOODROOFE M. N. et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med., 1995, 182 : 1985-1996.